Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Keiichi MURAKAMI"'
Autor:
Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Aiko Sueta, Keiichi Murakami, Hirotaka Iwase
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract The somatic activation of PI3K/AKT pathway mutations, PIK3CA and AKT1, and ESR1 mutations in plasma cell-free DNA (cfDNA) has been studied as a non-invasive procedure to quickly assess and monitor disease progression or therapeutic effect in
Externí odkaz:
https://doaj.org/article/8051e735bd994470b2803d53881588e8
Autor:
Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Aiko Sueta, Mai Tomiguchi, Keiichi Murakami, Yoko Omoto, Hirotaka Iwase
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background ESR1 mutations have attracted attention as a potentially important marker and treatment target in endocrine therapy-resistant breast cancer patients. The E380Q mutation, which is one of the ESR1 mutations, is associated with estra
Externí odkaz:
https://doaj.org/article/580f7920044e4ef88faff899288a3722
Autor:
Takashi Takeshita, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Mai Tomiguchi, Aiko Sueta, Keiichi Murakami, Yoko Omoto, Hirotaka Iwase
Publikováno v:
Translational Oncology, Vol 10, Iss 5, Pp 766-771 (2017)
BACKGROUND: ESR1 mutation in circulating cell-free DNA (cfDNA) is emerging as a noninvasive biomarker of acquired resistance to endocrine therapy, but there is a paucity of data comparing the status of ESR1 gene in cfDNA with that in its correspondin
Externí odkaz:
https://doaj.org/article/02056249fdb041ca9df4e5f943f41eb6
Autor:
Shinji Nagai, Atsushi Hashimoto, Seigo Koga, Akiko Hidaka, Keiichi Murakami, Rie Tagai, Ryo Nakamura, Yasuhide Watanabe, Kenji Hayashi
Publikováno v:
Journal of Spacecraft and Rockets. 60:22-37
The dynamic stability of a reentry lifting capsule with a large aftbody was studied by synergistic experimental and numerical investigations. Free-to-rotate wind-tunnel tests showed that self-induced pitch oscillations depended on the Mach number, Re
Autor:
Yuki Kikuchi, Toshihiro Sato, Keiichi Murakami, Tatsui Otsuka, Terufumi Machida, Keigo Yoshikawa, Yoshiaki Shiozawa, Hiroshi Komatsu, Masamitsu Maekawa, Nariyasu Mano, Hiroaki Tomita
Publikováno v:
Journal of Clinical Psychopharmacology; Mar/Apr2024, Vol. 44 Issue 2, p185-187, 3p
Autor:
Shota Endo, Dai Kezuka, Yi Li Wong, So Itoi, Toshiyuki Takai, Masanori Inui, Akiko Sugahara-Tobinai, Mei Tzu Su, Keiichi Murakami, Ari Itoh-Nakadai, Shotaro Miyamoto, Hisashi Arase, Karin Ono, Maika Takahashi, Kouyuki Hirayasu
Publikováno v:
International Immunology. 33:447-458
The extracellular matrix (ECM) is the basis for virtually all cellular processes and is also related to tumor metastasis. Fibronectin (FN), a major ECM macromolecule expressed by different cell types and also present in plasma, consists of multiple f
Autor:
Keiichi Murakami, Toshiya Yokoi, Takayuki Kojima, Hidekazu Yoshida, Sho Wakabayashi, Masakazu Sano, Tetsuya Sato, Takahiro Chiga, Atsushi Hashimoto, Hideyuki Taguchi
Publikováno v:
TRANSACTIONS OF THE JAPAN SOCIETY FOR AERONAUTICAL AND SPACE SCIENCES, AEROSPACE TECHNOLOGY JAPAN. 19:135-143
形態: カラー図版あり
Physical characteristics: Original contains color illustrations
Accepted: 2020-09-10
資料番号: PA2120009000
Physical characteristics: Original contains color illustrations
Accepted: 2020-09-10
資料番号: PA2120009000
Autor:
Rie Tagai, Yasuhide Watanabe, Atsushi Hashimoto, Shinji Nagai, Kenji Hayashi, Keiichi Murakami, Ryo Nakamura, Seigo Koga, Akiko Hidaka
Publikováno v:
AIAA Scitech 2021 Forum.
Autor:
Shinji Nagai, Atsushi Hashimoto, Seigo Koga, Akiko Hidaka, Keiichi Murakami, Rie Tagai, Ryo Nakamura, Yasuhide Watanabe, Kenji Hayashi
Publikováno v:
AIAA Scitech 2021 Forum.
Autor:
Keiichi Murakami, Yutaka Yamamoto, Hirotaka Iwase, Takashi Takeshita, Mutsuko Yamamoto-Ibusuki, Aiko Sueta, Mai Tomiguchi
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-6 (2018)
Molecular Cancer
Molecular Cancer
The somatic activation of PI3K/AKT pathway mutations, PIK3CA and AKT1, and ESR1 mutations in plasma cell-free DNA (cfDNA) has been studied as a non-invasive procedure to quickly assess and monitor disease progression or therapeutic effect in breast c